PharmaSource: The External Manufacturing Community Your Biopharma Outsourcing Intelligence Hub Trusted by 50,000+ biopharma manufacturing professionals Sign up for Newsletter LATEST NEWS WuXi Biologics Receives ANVISA GMP Certification for Three Manufacturing Facilities WuXi Biologics Receives ANVISA GMP Certification for Three Manufacturing Facilities AustinPx Partners with Thermo Fisher to Expand KinetiSol Technology for Commercial Manufacturing Lonza Expands ADC Payload-Linker Manufacturing Capacity at Visp Site Evotec Expands Just – Evotec Biologics with New J.TRAIN Manufacturing Platform ACRO Urges FDA to Include CROs in AI Clinical Trial Pilot Merck KGaA to Acquire Bio-Techne in $11.3 Billion Deal PROTAC CDMO: Contract Services, Market Growth & Outsourcing Guide 2026 C Ray Therapeutics Obtains First Category C Radiopharmaceutical Manufacturing License Under New NMPA Rules WuXi Biologics Completes First GMP Production at MFG17 Drug Substance Facility Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success ICON Reports $3.3B in Gross Bookings and 1.42x Net Book-to-Bill in Q1 2026 as CRO Backlog Reaches $22.7B AustinPx Partners with Thermo Fisher to Expand KinetiSol Technology for Commercial Manufacturing Lonza Expands ADC Payload-Linker Manufacturing Capacity at Visp Site Evotec Expands Just – Evotec Biologics with New J.TRAIN Manufacturing Platform PODCASTS Tariffs, FDA Chaos, and BioSecure in Limbo: How CDMOs Should Operate Under Uncertainty How Sandoz Cut Its Supplier Network by 34%: A Step-by-Step Consolidation Playbook SPOTLIGHT Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success RESOURCES Resilience, Risk & Relationships – ExM Leaders Report [DOWNLOAD] Partnerships for an Uncertain World: The CDMO Live Europe 2026 Report Avoiding the Pitfalls: Five Lessons for Cell Therapy Manufacturing Success UPCOMING EVENTS External Manufacturing Leaders Basel 2026 CDMO Live Europe 2027 CDMO Live Americas 2026
C Ray Therapeutics Obtains First Category C Radiopharmaceutical Manufacturing License Under New NMPA Rules
ICON Reports $3.3B in Gross Bookings and 1.42x Net Book-to-Bill in Q1 2026 as CRO Backlog Reaches $22.7B